Close

UPDATE: Roth Capital Downgrades Inovio Pharmaceuticals (INO) to Sell

November 17, 2020 7:34 AM EST Send to a Friend
(Updated - November 17, 2020 7:36 AM EST)

(updating comment)Roth Capital analyst Jonathan Aschoff downgraded Inovio Pharmaceuticals (NASDAQ: INO) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login